Overview Financials News + Filings IR Vault Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Quarterly results
CC transcript
|
|
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
4
| Barbo William D (Corporate Executive VP & CCO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Sold 5,763 shares
@ $217.24, valued at
$1.3M
Exercised 5,511 options to buy
@ $144.67, valued at
$797.3k
|
|
| 08/14/2023 |
4
| Knell Michael Gunnar (CSVP&Chief Accounting Officer) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Sold 1,471 shares
@ $216.54, valued at
$318.5k
Exercised 1,471 options to buy
@ $144.67, valued at
$212.8k
|
|
| 08/14/2023 |
4
| FOSTER JAMES C (Chairman, President and CEO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Gifted 2,500 shares
@ $0 |
|
| 08/14/2023 |
4
| LaPlume Joseph W (EVP, Corp Strategy & Develop) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Sold 700 shares
@ $216.52, valued at
$151.6k
|
|
| 07/05/2023 |
4
| MACKAY MARTIN (Director) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 95 shares
@ $0 |
|
| 06/02/2023 |
4
| MACKAY MARTIN (Director) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 338 shares
@ $0 |
|
| 05/31/2023 |
4
| LaPlume Joseph W (EVP, Corp Strategy & Develop) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 2,189 shares
@ $0
Paid exercise price by delivering 184 shares
@ $194.12, valued at
$35.7k
Paid exercise price by delivering 125 shares
@ $194.12, valued at
$24.3k
Paid exercise price by delivering 223 shares
@ $194.12, valued at
$43.3k
Granted 5,252 options to buy
@ $194.12, valued at
$1M
|
|
| 05/31/2023 |
4
| Knell Michael Gunnar (CSVP&Chief Accounting Officer) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 670 shares
@ $0
Paid exercise price by delivering 36 shares
@ $194.12, valued at
$7k
Paid exercise price by delivering 24 shares
@ $194.12, valued at
$4.7k
Paid exercise price by delivering 36 shares
@ $194.12, valued at
$7k
Granted 1,607 options to buy
@ $194.12, valued at
$312k
|
|
| 05/31/2023 |
4
| Pease Flavia (Corporate Executive VP & CFO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 2,215 shares
@ $0
Paid exercise price by delivering 137 shares
@ $194.12, valued at
$26.6k
Granted 5,314 options to buy
@ $194.12, valued at
$1M
|
|
| 05/31/2023 |
4
| FOSTER JAMES C (Chairman, President and CEO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Paid exercise price by delivering 1,274 shares
@ $194.12, valued at
$247.3k
Granted 28,176 options to buy
@ $194.12, valued at
$5.5M
|
|
| 05/31/2023 |
4
| Barbo William D (Corporate Executive VP & CCO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 1,958 shares
@ $0
Paid exercise price by delivering 166 shares
@ $194.12, valued at
$32.2k
Paid exercise price by delivering 112 shares
@ $194.12, valued at
$21.7k
Paid exercise price by delivering 202 shares
@ $194.12, valued at
$39.2k
Granted 4,696 options to buy
@ $194.12, valued at
$911.6k
|
|
| 05/31/2023 |
4
| Girshick Birgit (Corporate Executive VP & COO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 3,812 shares
@ $0
Paid exercise price by delivering 242 shares
@ $194.12, valued at
$47k
Paid exercise price by delivering 132 shares
@ $194.12, valued at
$25.6k
Paid exercise price by delivering 216 shares
@ $194.12, valued at
$41.9k
Granted 9,145 options to buy
@ $194.12, valued at
$1.8M
|
|
| 05/31/2023 |
4
| Parisotto Shannon M (CEVP, Disc & Safety Assessment) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 1,700 shares
@ $0
Paid exercise price by delivering 105 shares
@ $194.12, valued at
$20.4k
Paid exercise price by delivering 71 shares
@ $194.12, valued at
$13.8k
Paid exercise price by delivering 110 shares
@ $194.12, valued at
$21.4k
Granted 4,078 options to buy
@ $194.12, valued at
$791.6k
|
|
| 05/31/2023 |
4
| Creamer Victoria L (EVP & Chief People Officer) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 2,009 shares
@ $0
Paid exercise price by delivering 170 shares
@ $194.12, valued at
$33k
Paid exercise price by delivering 115 shares
@ $194.12, valued at
$22.3k
Paid exercise price by delivering 190 shares
@ $194.12, valued at
$36.9k
Granted 4,820 options to buy
@ $194.12, valued at
$935.7k
|
|
| 05/17/2023 |
4
| WALLMAN RICHARD F (Director) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 664 shares
@ $0
Granted 1,669 options to buy
@ $192.36, valued at
$321k
|
|
| 05/17/2023 |
4
| FOSTER JAMES C (Chairman, President and CEO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Gifted 3,811 shares
@ $0
Gifted 3,812 shares
@ $0 |
|
| 05/17/2023 |
4
| Llado George Sr. (Director) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 664 shares
@ $0
Granted 1,669 options to buy
@ $192.36, valued at
$321k
|
|
| 05/17/2023 |
4
| Kochevar Deborah Turner (Director) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 664 shares
@ $0
Granted 1,669 options to buy
@ $192.36, valued at
$321k
|
|
| 05/17/2023 |
4
| BERTOLINI ROBERT J (Director) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 664 shares
@ $0
Granted 468 shares
@ $0
Granted 1,669 options to buy
@ $192.36, valued at
$321k
|
|
| 05/17/2023 |
4
| Andrews Nancy C (Director) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 664 shares
@ $0
Granted 1,669 options to buy
@ $192.36, valued at
$321k
|
|
| 05/15/2023 |
4
| LaPlume Joseph W (EVP, Corp Strategy & Develop) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Sold 950 shares
@ $193.02, valued at
$183.4k
Sold 9 shares
@ $194.07, valued at
$1.7k
|
|
| 05/15/2023 |
4
| MASSARO GEORGE (Director) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Sold 288 shares
@ $193.43, valued at
$55.7k
|
|
| 03/08/2023 |
4
| Girshick Birgit (Corporate Executive VP & COO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Gifted 475 shares
@ $0 |
|
| 02/24/2023 |
4
| WALLMAN RICHARD F (Director) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Bought 1,750 shares
@ $220.73, valued at
$386.3k
|
|
| 02/22/2023 |
4
| Creamer Victoria L (EVP & Chief People Officer) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Paid exercise price by delivering 343 shares
@ $248.21, valued at
$85.1k
Paid exercise price by delivering 181 shares
@ $243.6, valued at
$44.1k
|
|
| 02/22/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2023 |
4
| Knell Michael Gunnar (CSVP&Chief Accounting Officer) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Paid exercise price by delivering 51 shares
@ $243.6, valued at
$12.4k
|
|
| 02/22/2023 |
4
| Barbo William D (Corporate Executive VP & CCO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Paid exercise price by delivering 287 shares
@ $243.6, valued at
$69.9k
|
|
| 02/22/2023 |
4
| LaPlume Joseph W (EVP, Corp Strategy & Develop) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Paid exercise price by delivering 317 shares
@ $243.6, valued at
$77.2k
|
|
| 02/22/2023 |
4
| Girshick Birgit (Corporate Executive VP & COO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Paid exercise price by delivering 308 shares
@ $243.6, valued at
$75k
|
|
| 02/21/2023 |
4
| Parisotto Shannon M (CEVP, Disc & Safety Assessment) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Sold 116 shares
@ $246.0172, valued at
$28.5k
Sold 194 shares
@ $248.1594, valued at
$48.1k
Sold 158 shares
@ $250.5584, valued at
$39.6k
Sold 19 shares
@ $251.525, valued at
$4.8k
Sold 264 shares
@ $252.2777, valued at
$66.6k
Sold 451 shares
@ $253.4193, valued at
$114.3k
Sold 533 shares
@ $254.2232, valued at
$135.5k
Sold 1,674 shares
@ $255.4787, valued at
$427.7k
Sold 994 shares
@ $256.1991, valued at
$254.7k
Sold 155 shares
@ $257.052, valued at
$39.8k
Exercised 4,558 options to buy
@ $109.34, valued at
$498.4k
|
|
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/30/2023 |
4
| Parisotto Shannon M (CEVP, Disc & Safety Assessment) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 4,820 shares
@ $0
Paid exercise price by delivering 1,309 shares
@ $244.49, valued at
$320k
|
|
|
|
|